Clinical Trial Update: Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial using riluzole for Spinocerebellar Ataxia Type 2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinocerebellar Ataxia Type 2

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Spinocerebellar Ataxia Type 2 | Phase 3 | Status: COMPLETED